Adenosine dry powder inhalation for bronchial challenge testing, part 1: Inhaler and formulation development and in vitro performance testing

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 86, Issue 1, 2014, Pages 105-114

  Lexmond, Anne J ^a   Hagedoorn, Paul ^a   Van Der Wiel, Erica ^b   Ten Hacken, Nick H T ^b   Frijlink, Henderik W ^a   De Boer, Anne H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adenosine; Adenosine 5 monophosphate; Air classifier technology; Bronchial challenge test; Dry powder inhaler

Indexed keywords

ADENOSINE; DILUENT; LACTOSE;

AEROSOL; ARTICLE; CLASSIFIER; DISPERSION; DRUG FORMULATION; DRY POWDER; DRY POWDER INHALER; IN VITRO STUDY; INHALATION TEST; PARTICLE SIZE; PROVOCATION TEST; SPRAY DRYING;

ADENOSINE; ADENOSINE 5′-MONOPHOSPHATE; AIR CLASSIFIER TECHNOLOGY; BRONCHIAL CHALLENGE TEST; DRY POWDER INHALER;

ADENOSINE; ADMINISTRATION, INHALATION; AEROSOLS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRY POWDER INHALERS; EQUIPMENT DESIGN; MODELS, THEORETICAL; PARTICLE SIZE; PILOT PROJECTS; SURFACE PROPERTIES;

EID: 84896697654     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.06.027     Document Type: Article

References (26)

1. P.J. Sterk, L.M. Fabbri, P.H. Quanjer, D.W. Cockcroft, P.M. O'Byrne, and S.D. Anderson et al. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults Eur. Respir. J. 6 Suppl. 16 1993 53 83
2. R. Pauwels, G. Joos, and M. Van der Straeten Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma Clin. Allergy 18 1988 317 321
3. D.W. Cockcroft Provocation methods: direct challenges Clin. Rev. Allergy Immunol. 24 2003 19 26
4. M.J. Cushley, A.E. Tattersfield, and S.T. Holgate Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects Br. J. Clin. Pharmacol. 15 1983 161 165
5. M. Van den Berge, R. Polosa, H.A.M. Kerstjens, and D.S. Postma The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease J. Allergy Clin. Immunol. 114 2004 737 746
6. M. Van den Berge, R.J. Meijer, H.A.M. Kerstjens, D.M. De Reus, G.H. Koeter, and H.F. Kauffman et al. PC(20) adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine Am. J. Respir. Crit. Care Med. 165 2002 1546 1550
7. G. De Meer, D. Heederik, and D.S. Postma Bronchial responsiveness to adenosine 5′-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV 1 Am. J. Respir. Crit. Care Med. 165 2002 327 331
8. R.O. Crapo, R. Casaburi, A.L. Coates, PL. Enright, J.L. Hankinson, and C.G. Irvin et al. American Thoracic Society guidelines for methacholine and exercise challenge testing - 1999 Am. J. Respir. Crit. Care Med. 161 2000 309 329
9. G.F. Joos, and B. O'Connor Indirect airway challenges Eur. Respir. J. 21 2003 1050 1068
10. A.J. Lexmond, P. Hagedoorn, H.W. Frijlink, A.H. De Boer, Challenging the two-minute tidal breathing challenge test, doi: http://dx.doi.org/10.1089/jamp. 2012.1021.
11. O.S. Usmani, M.F. Biddiscombe, and P.J. Barnes Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size Am. J. Respir. Crit. Care Med. 172 2005 1497 1504
12. A.H. De Boer, P. Hagedoorn, E.M. Westerman, P.P.H. Le Brun, H.G.M. Heijerman, and H.W. Frijlink Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses Eur. J. Pharm. Sci. 28 2006 171 178
13. A.R. Clark, and A.M. Hollingworth The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers - implications for in vitro testing J. Aerosol Med. 6 1993 99 110
14. E. Van der Wiel, N.H.T. Ten Hacken, D.S. Postma, and M. Van den Berge Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review J. Allergy Clin. Immunol. 131 2013 646 657
15. J. Cohen, D.S. Postma, W.R. Douma, J.M. Vonk, A.H. De Boer, and N.H.T. Ten Hacken Particle size matters: diagnostics and treatment of small airways involvement in asthma Eur. Respir. J. 37 2011 532 540
16. A.H. De Boer, P. Hagedoorn, D. Gjaltema, J. Goede, and H.W. Frijlink Air classifier technology (ACT) in dry powder inhalation Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures Int. J. Pharm. 260 2003 187 200
17. G.S. Zijlstra, W.L.J. Hinrichs, A.H. De Boer, and H.W. Frijlink The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix Eur. J. Pharm. Sci. 23 2004 139 149
18. * comparison of the two American Thoracic Society-recommended methods Chest 125 2004 453 458
19. L. Prieto, I. Reig, R. Rojas, A. Ferrer, and J. Domenech The effect of challenge method on sensitivity and reactivity to adenosine 5′- monophosphate in subjects with suspected asthma Chest 130 2006 1448 1453
20. W. Sarlikiotis, A.H. De Boer, Particulate Formulation for Administration by Inhalation, U.S. Patent 6,284,287, 2001.
21. A.H. De Boer, D. Gjaltema, P. Hagedoorn, M. Schaller, W. Witt, and H.W. Frijlink Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols Int. J. Pharm. 249 2002 233 245
22. F. Grasmeijer, P. Hagedoorn, H.W. Frijlink, and A.H. De Boer Characterisation of high dose aerosols from dry powder inhalers Int. J. Pharm. 437 2012 242 249
23. M. Timsina, G. Martin, and C. Marriott Drug delivery to the respiratory tract using dry powder inhalers Int. J. Pharm. 101 1994 1 13
24. M. Vidgren, P. Vidgren, and T. Paronen Comparison of physical and inhalation properties of spray-dried and mechanically micronized disodium cromoglycate Int. J. Pharm. 35 1987 139 144
25. V. Naini, P.R. Byron, and E.M. Phillips Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers Drug Dev. Ind. Pharm. 24 1998 895 909
26. M.E.A.C. Broeders, J. Molema, W.C.J. Hop, and H.T.M. Folgering Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction J. Aerosol Med. 16 2003 131 141